Skip to main content
News ImmunStep 02.2020
© ImmunStep

News categories: Honors & Funding

ImmunoSep supported by Horizon2020

The EU-Research Projekt ImmunoSep starts and members of the Cluster of Excellence ImmunoSensation Mihai Netea and Joachim L. Schultze are part of the research consortium led by the Radboud University Medical Center, Nijmegen, Netherlands.

Within the next 4 years more then 10 Million Euro are provided by the EU-wide Horizon2020 program and the University of Bonn will receive around 750.000 Euro.

Sepsis is a life-threatening condition caused by the body’s response to a bacterial, fungal or viral infection. Most frequently it affects adults over the age of 65, children younger than one year of age, people with chronic medical conditions such as diabetes, lung disease, cancer, and kidney disease as well as those with a weakened immune system. Unfortunately, sepsis is still a common occurrence with an estimated 50 million cases occurring worldwide each year. It is one of the most common causes of death for hospitalised patients in European countries with a high mortality rate of 30-40%. Even though the prescription of antibiotics and the establishment of Intensive Care Units (ICUs) have already greatly reduced the number of sepsis-related deaths, the introduction of an immunotherapy approach is intended to greatly improve the outcome of the disease for those affected.

This is where ImmunoSep comes into play. While past studies have promoted a ‘one-size-fits-all’ treatment approach, this multinational project focuses on the exploration of personalised immunotherapy. This takes into account that although overinflammation and immunoparalysis play a critical role in the physiological processes of sepsis, they manifest differently in individual patients. Therefore only a precision medicine-based approach for immunotherapy will be able to significantly improve the outcome of this severe clinical condition.

Related news

Dermatologist Prof. Jörg Wenzel – from Bonn University Hospital (UKB) and the University of Bonn – leads the Bonn subproject within the new DFG-funded research consortium FOR 6059, which investigates the mechanisms underlying cutaneous lupus. © Bonn University Hospital (UKB) / Alessandro Winkler

News categories: Honors & Funding

New Research Group Investigates Cutaneous Lupus

—The German Research Foundation (DFG) is funding a new research group dedicated to investigating cutaneous lupus erythematosus, an autoimmune disease affecting the skin. A team from Bonn University Hospital (UKB) and the University of Bonn is participating in the collaborative research project “Investigating the Immunopathogenesis of Cutaneous Lupus Erythematosus” (FOR 6059), which is led by the Department of Dermatology at the University Hospital Tübingen.
View entry
With funding from the Corona Foundation, Dr Christina Mayer (right) is establishing her own junior research group and developing the field of neurovisual diagnostics at the Department of Neurology at UKB, headed by Prof Anne-Katrin Pröbstel (left).

News categories: Honors & Funding

The Retina as a Window into the Early Detection of Brain Diseases

—The retina is the only part of the central nervous system that can be examined non-invasively and at high resolution in living humans. Dr Christina Mayer and her team at Bonn University Hospital (UKB) and the University of Bonn aim to use this unique feature to detect inflammatory and vascular diseases of the brain earlier and more accurately, and to better understand how they develop. The Corona Foundation is providing €1 million to establish her junior research group. The programme gives outstanding early-career researchers the opportunity to qualify for a university professorship.
View entry
Prof. Joanna Kalucka joins Bonn as a Mercator Fellow and investigates how metabolic and inflammatory processes affect the inner lining of blood vessels.

News categories: Honors & Funding

Joanna Kalucka Joins Bonn as a Mercator Fellow

—Joanna Kalucka, Associate Professor at Aarhus University’s Department of Biomedicine, will join the Collaborative Research Centre (CRC) 1454 “Metaflammation and Cellular Programming” at the University of Bonn and Bonn University Hospital (UKB) as a Mercator Fellow Global from 2027. The German Research Foundation (DFG) is funding her fellowship through the “1000 Heads Plus” programme of the Federal Ministry of Research, Technology and Space (BMFTR).
View entry

Back to the news overview